What does ACTRIMS stand for?

Americas Committee for Treatment and Research in Multiple Sclerosis (Canada and US)

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.
Organizations, NGOs, schools, universities, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Atlantic Canada Trail Riding Association (est. 1980) Australian Capital Territory Rowing Association Acoustic Transmission Analog Computer Translator Alameda-Contra Costa Transit District (California) Bureau for Workers' Activities (International Labour Office) Advanced Centre for Treatment, Research and Education in Cancer (India) Activity Report Activation Request Activin A Receptor, Type IIB		Acoustic Trial Association Canadienne des Technologues en Radiation Médicale Advisory Committee on Tenure-Related Processes Association of Consulting Town and Regional Planners (South Africa) Agency Candidate System Amel Center for Treatment and Rehabilitation of Victims of Torture Altadena Crest Trail Restoration Working Group (South Pasadena, CA) Aboriginal Christian Training Services (Tweed Heads, New South Wales, Australia) Abundant Care Training Services (Detroit, MI) Access to Care, Treatment and Support (HIV/AIDS)

Samples in periodicals archive:

OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, presented positive interim research findings of its Phase I/II clinical trials of Tovaxin(TM), a novel T cell therapeutic vaccine for Multiple Sclerosis on Friday, September 30, 2005, at the 21st European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the 10th Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) congress held in Thessaloniki, Greece.

PharmaFrontiers Presents Positive Tovaxin(TM) Research at ...

OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, announced today that their research of their Phase I/II clinical trials of Tovaxin(TM), a novel T cell therapeutic vaccine for Multiple Sclerosis, has been accepted for presentation at the 21st Congress of the European Committee/10th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis to be held September 28 - October 1, 2005, in Thessaloniki, Greece.

PharmaFrontiers to Present Tovaxin(TM) Research at International ...